Edition:
United Kingdom

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.40USD
16 Jul 2019
Change (% chg)

-- (--)
Prev Close
$1.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
108,013
52-wk High
$1.80
52-wk Low
$0.43

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Mar-19 3 0.00 0.00 0.00 --
Year Ending Mar-20 2 0.00 0.00 0.00 1.28
Year Ending Mar-21 3 6.62 16.00 0.00 3.96
Earnings (per share)
Quarter Ending Dec-19 1 -0.14 -0.14 -0.14 --
Quarter Ending Mar-19 2 -0.08 -0.05 -0.11 --
Year Ending Mar-19 2 -0.69 -0.54 -0.84 --
Year Ending Mar-20 3 -0.38 -0.17 -0.56 -0.40
Year Ending Mar-21 2 -0.12 -0.05 -0.19 -0.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.88 32.67
P/E High - Last 5 Yrs. -- 42.96 47.29
P/E Low - Last 5 Yrs. -- 23.36 23.87
Beta -- 0.89 0.89
Price to Sales (TTM) -- 6.26 7.92
Price to Book (MRQ) -- 5.26 5.39
Price to Tangible Book (MRQ) -- 5.93 6.71
Price to Cash Flow (TTM) -- 23.51 24.37
% Owned Institutions -- 0.75 1.45

Dividends

  Company industry sector
Dividend Yield -- 1.42 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.38
Dividend 5 Year Growth Rate -- 3.90 4.54
Payout Ratio(TTM) -- 42.61 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.12 12.24
Sales (TTM) vs TTM 1 Yr. Ago -- 6.49 7.75
Sales - 5 Yr. Growth Rate -- 10.59 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 40.64 43.00
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.80 10.33
Capital Spending - 5 Yr. Growth Rate -- 15.44 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.21
Current Ratio (MRQ) -- 2.93 3.03
LT Debt to Equity (MRQ) -- 7.95 10.21
Total Debt to Equity (MRQ) -- 11.65 14.57
Interest Coverage (TTM) -- 32.88 29.24

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.83 52.21
Gross Margin - 5 Yr. Avg. -- 49.67 50.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.40 13.16
Operating Margin (TTM) -- 13.79 6.89
Operating Margin - 5 Yr. Avg. -- 13.96 8.97
Pre-Tax Margin (TTM) -- 12.42 6.09
Pre-Tax Margin - 5 Yr. Avg. -- 14.37 9.26
Net Profit Margin (TTM) -- 9.21 2.72
Net Profit Margin - 5 Yr. Avg. -- 10.80 5.63
Effective Tax Rate (TTM) -- 22.44 22.40
Effective Tax Rate - 5 Yr. Avg. -- 22.49 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 993,588,171 887,658,316
Net Income/Employee (TTM) -- 114,088,254 101,887,456
Receivable Turnover (TTM) -- 5.96 5.94
Inventory Turnover (TTM) -- 2.62 3.36
Asset Turnover (TTM) -- 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.51 11.18
Return on Assets - 5 Yr. Avg. -- 12.96 12.34
Return on Investment (TTM) -- 14.90 14.49
Return on Investment - 5 Yr. Avg. -- 16.86 16.03
Return on Equity (TTM) -- 16.02 15.79
Return on Equity - 5 Yr. Avg. -- 17.66 17.01
Note: Units in Millions of US Dollars

Performance for Acasti Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.